The Medtronic Extravascular Implantable Cardioverter Defibrillator, or EV ICD system, is designed to treat dangerously fast heart rhythms that can lead to sudden cardiac arrest, while avoiding some of the risks of traditional, transvenous ICDs because its lead (thin wire) is placed outside the heart and the veins. below the sternum (sternum) using a minimally invasive approach. The company noted that the placement of the lead is designed to help prevent long-term complications that can be associated with leads in the heart and veins, such as vessel occlusion (narrowing, blockage, or compression of a vein) and risks for blood infections. The cable is connected to a device that is implanted under the left armpit. Clinical trial participants received the same therapies provided by traditional ICDs, including defibrillation, antitachycardia pacing (ATP), and backup pacing therapies with this unique implantable device that is similar in size, shape, and longevity to traditional ICDs. For more such health news, visit rttnews.com The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.
